Standardised neutralising antibody assays are needed for evaluating COVID-19 vaccines
Enregistré dans:
Auteur principal: | Youchun Wang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a902fe37926e407b8b32a2c78c39b0d7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Preparticipation medical evaluation for elite athletes: EFSMA recommendations on standardised preparticipation evaluation form in European countries
par: Xavier Bigard, et autres
Publié: (2021) -
Implementation and 1-year follow-up of the cardiovascular ICU standardised handover
par: Monica Lupei, et autres
Publié: (2021) -
Identification of neutralising pembrolizumab anti-drug antibodies in patients with melanoma
par: S. C. Sasson, et autres
Publié: (2021) -
Exploration of a quality improvement process to standardised preoperative tests for a surgical procedure to reduce waste
par: Brian Taylor, et autres
Publié: (2021) -
Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles
par: Huang KW, et autres
Publié: (2012)